Crunching Data

The Savings Opportunity

Contulen® (Sertraline) tablets are priced below the Category M Drug Tariff price offering substantial savings if written as Contulen.³

As the Category M Drug Tariff price changes each quarter HFA Healthcare will guarantee that their list price will remain below the drug tariff price offering guaranteed savings.

Replacing generic and other branded Sertraline 100mg and 50mg with Contulen 100mg and 50mg could have saved your £7,250,409.00 per year.⁵

The switch from generic and other branded Sertraline 100mg and 50mg should be relatively straight forward and require little effort.

How can the switch be implemented?

The switch to Contulen 100mg and 50mg can be implemented in the following ways:

1. Prescribing Newsletters - ICBs can communicate this switch strategy and the potential savings opportunity to prescribers.

2. ScriptSwitch®/Optimize Rx®- Can be used to remind prescribers about the financial savings Contulen 100mg and 50mg prescribing offers over generic Duloxetine 30mg and 60mg at prescription initiation and review.

3. ICB Formulary - Can highlight the preferred option of Contulen 100mg and 50mg over generic and other branded Sertraline 100mg and 50mg.

4. Joint Formulary - Can highlight the preferred option of Contulen 100mg and 50mg across all sub-ICBs and hospital trusts in a health economy.

5. ICB Prescribing Adviser - ICB Prescribing Adviser to cascade to Practice Pharmacists where patients identified for switch.

Prescribing Information

Prescribing Information on request from HFA Healthcare Limited

References:
1,2: April 2023 - March 2024 NHS GP Prescribing Data for England and Scotland; data includes Sertraline generic plus brand; 3: Drug Tariff / NHS List prices as of March 2024; 4: Forecasted Sertraline spend based on packs prescribed from April 2023 - March 2024 and replacing all Sertraline prescribing from April 2023 - March 2024 with Contulen (calculations based on March 2024 Drug Tariff / NHS List prices); 5: HFA data on file October 2024.